| Ytd | 11.60% | |
| 1y | 39.40% |
| Open | 136.50 | Prev Close | 136.38 | Low | 133.68 | High | 136.48 | Mkt Cap | 18.17B |
| Vol | 1.71M | Avg Vol | 1.43M | EPS | 2.33 | P/E | 57.76 | Forward P/E | 16.89 |
| Beta | 1.09 | Short Ratio | 2.33 | Inst. Own | 79.72% | Dividend | 2.40 | Div Yield | 1.75 |
| Ex Div Date | 08-31 | Earning | 11-05 | 50-d Avg | 139.13 | 200-d Avg | 136.35 | 1yr Est | 170.00 |
Flow Cleanrooms & Supply expands availability of DuPont™ Tyvek® cleanroom garments for contamination
The Zacks Chemicals Diversified is expected to benefit from healthy demand across major end-use mark
DuPont's MemCor MBR system will add about 97 million liters per day of treatment capacity in Canberr
Recognition highlights the collaborative efforts behind DuPont's recently launched end-to-end direct
The Lower Molonglo Water Quality Control Center will become the largest MBR plant in Australia with
JP Morgan analyst Chigusa Katoku maintains DuPont de Nemours (NYSE:DD) with a Overweight and rais
A federal judge on Friday approved more than $2.5 billion of settlements that New Jersey reached wi
RBC Capital analyst Arun Viswanathan maintains DuPont de Nemours (NYSE:DD) with a Outperform and
https://www.ft.com/content/77f00cf3-f2e6-4dcb-bf0d-1631ca45dd9c?syn-25a6b1a6=1&_gl=1*1lkg4gt*_up
Award-winning DuPont™ Liveo™ Pharma TPE Ultra-Low Temp Tubing advances biopharma processing applicat
On August 05, 2026, DuPont de Nemours Inc (DD) shares rose 3.1% to a current price of $147.37. Over
UBS analyst Joshua Spector maintains DuPont de Nemours (NYSE:DD) with a Buy and raises the price
DuPont raises its 2026 outlook as pricing, productivity and key end markets point to faster second-h
New distribution alignment improves regional service, increases product availability, and provides c
Recognition highlights breakthrough membrane technology providing ultra-high brine concentration, wa
DuPont de Nemours NYSE: DD raised its full-year 2026 outlook after reporting second-quarter results
DuPont Earnings Outlook improves after a Q2 beat, but a narrower sales range and currency headwinds
DuPont de Nemours, Inc. (DD) Q2 2026 Earnings Call Transcript
DuPont topped Q2 earnings and sales estimates, boosted by healthcare, industrial water and aerospace
DuPont de Nemours (NYSE:DD) is looking for Q3 Adj EPS of $1.80-$1.90 vs $1.93 analyst estimate. sees
While the top- and bottom-line numbers for DuPont de Nemours (DD) give a sense of how the business p
DuPont de Nemours (NYSE:DD) reported second-quarter financial results on Tuesday. The transcript fro
DuPont de Nemours Inc (DD) released its 8-K filing on August 4, 2026, reporting robust financial res
DuPont de Nemours reported a higher profit in the second quarter as sales rose across the chemicals
DuPont de Nemours (NYSE:DD) raises FY2026 Adj EPS guidance from $7.02-$7.16 to $7.17-$7.32 vs $7.13
Exceeds Second Quarter 2026 Guidance Raises Full Year 2026 Guidance Second Quarter 2026 Highlights N
DD is expected to have benefited from its innovation-driven investment, productivity actions and acq
A recovery in end-market demand and self-help measures, including cost cuts and productivity gains,
Spinning off business units for companies can unlock shareholder value. Market expert Jay Woods shar
Morgan Stanley analyst Vincent Andrews maintains DuPont de Nemours (NYSE:DD) with a Equal-Weight
Qnity Electronics shares rose 2.85% after hours as investors reacted to the CEO’s upbeat comments on
DuPont de Nemours (NYSE:DD) affirms FY2026 Adj EPS guidance from $7.02-$7.16 to $7.02-$7.16 vs $7.17
RBC Capital analyst Arun Viswanathan maintains DuPont de Nemours (NYSE:DD) with a Outperform and
UBS analyst Joshua Spector maintains DuPont de Nemours (NYSE:DD) with a Buy and raises the price
DuPont (NYSE: DD) beats Q1 estimates with $1.68B in sales and 15% EBITDA growth. Shares rose over 7%
DuPont de Nemours (NYSE:DD) is looking for Q2 Adj EPS of $0.59 vs $0.58 analyst estimate. sees sales
DuPont de Nemours (NYSE:DD) raises FY2026 Adj EPS guidance from $2.25-$2.30 to $2.35-$2.40 vs $2.27
DuPont de Nemours (NYSE:DD) reported quarterly earnings of $0.55 per share which beat the analyst co
RBC Capital analyst Arun Viswanathan maintains DuPont de Nemours (NYSE:DD) with a Outperform and
Citigroup analyst Patrick Cunningham maintains DuPont de Nemours (NYSE:DD) with a Buy and lowers
DuPont (DD) shares slip premarket as risk appetite softens. Explore technical analysis, support leve
DuPont (NYSE: DD) today announced the launch of the upgraded FilmTec™ NF270-400/34 nanofiltration el
Women remain scarce in the C‑suite, with only a fraction of large U.S. companies led by female CEOs.
DuPont de Nemours, Inc., a Delaware corporation, expects to close the previously announced sale of i
https://www.bloomberg.com/news/articles/2026-03-04/goldman-further-sweetens-terms-on-loan-for-dupont
https://www.bloomberg.com/news/articles/2026-02-20/goldman-weighs-sweeter-terms-on-loan-tied-to-dupo
Deutsche Bank analyst David Begleiter maintains DuPont de Nemours (NYSE:DD) with a Buy and raises